Toxoplasmosis in Cats: Zoonotic Risk from Oocyst Shedding and Feline Brain Infection

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. The parasite can infect all warm-blooded animals, including birds and mammals [3, 4]. Felids, both domestic and wild, serve as the definitive hosts in the epidemiology of toxoplasmosis because they are the only species capable of excreting environmentally resistant oocysts in their feces [1, 5]. This unique role positions cats as the central amplifier for environmental contamination, posing a direct zoonotic risk to humans and other intermediate hosts [5, 6, 7]. This review provides an exhaustive analysis of the biological mechanisms of oocyst shedding, the pathogenesis of feline brain infection, diagnostic methodologies, treatment protocols, and control strategies, with a strict focus on veterinary and comparative pathology.

Life Cycle and Transmission Biology

The life cycle of T. gondii involves two distinct phases: the sexual cycle, which occurs exclusively in the intestinal epithelium of felids, and the asexual cycle, which occurs in all warm-blooded intermediate hosts [1, 8]. Cats become infected by ingesting tissue cysts from intermediate hosts (e.g., rodents, birds) or by ingesting sporulated oocysts from the environment [1, 9]. Upon ingestion of tissue cysts, bradyzoites are released in the stomach and small intestine, invade enterocytes, and initiate the sexual cycle, leading to the production of unsporulated oocysts [10]. These oocysts are shed in feces (toxoplasmosis in cat poop) for 1 to 3 weeks, with a single cat capable of excreting millions of oocysts [1, 5]. The pre-patent period after tissue cyst ingestion is typically 3 to 10 days, whereas oocyst ingestion leads to a longer pre-patent period of 18 days or more [1, 9]. Sporulation occurs in the environment within 1 to 5 days, rendering oocysts infectious [1].

Transmission to humans and other intermediate hosts occurs through three primary routes: oral ingestion of tissue cysts in undercooked meat, ingestion of food or water contaminated with sporulated oocysts, and congenital transmission via transplacental passage of tachyzoites [5, 4, 11]. Oocyst contamination of soil, water, and food is a major source of human outbreaks, highlighting the critical public health importance of feline shedding [5, 7].

Zoonotic Risk from Oocyst Shedding

The zoonotic risk posed by cats is predominantly linked to their ability to shed millions of oocysts into the environment [1, 5, 6]. These oocysts are extremely resilient and can remain infectious in soil and water for months to years [1, 12]. Studies have demonstrated a high prevalence of T. gondii DNA in feces of stray cats, with one investigation in Izmir, Turkey, detecting oocysts in 0.43% by microscopy and T. gondii DNA in 14.37% of fecal samples [7]. The same study reported a seroprevalence of 37.84% [7]. A study in Thailand found a higher prevalence of infection in semi-domesticated cats (11.5%) compared with pet cats (1.5%), with semi-domesticated cats having 8.34 times higher odds of infection [13]. This suggests that free-roaming and stray populations represent a more significant zoonotic reservoir [13, 14]. Research in Pakistan reported a significantly higher infection rate in stray cats (74.6%) than in pet cats (25.4%), further underscoring the role of stray populations in environmental contamination [14].

Risk factors associated with seropositivity in cats include older age, outdoor access, cat-fight trauma, and lack of routine vaccination [15]. A study from Greece found that older cats and those with a history of cat-fight trauma had significantly higher odds of T. gondii seropositivity [15]. Seroprevalence in healthy cat populations varies widely, ranging from 6% in a Turkish hospital population to 37.4% in a Slovakian mixed population and 95.5% in a district of Pakistan [3, 6, 14]. A Brazilian study found a seroprevalence of 15.2% by ELISA, indicating a high level of environmental contamination [5].

Parasite genotyping has revealed that a unique genotype (ToxoDB genotype #9 or Chinese 1) is widely prevalent in cats in China and has been epidemiologically linked to outbreaks of clinical toxoplasmosis in pigs and deaths in humans [1]. Genotype #4, commonly found in wildlife, has been associated with overwhelming disseminated toxoplasmosis in kittens [16]. These findings highlight that the zoonotic risk is not uniform and is influenced by both host ecology and parasite genetics.

Pathogenesis of Feline Brain Infection (Cat Toxoplasmosis Brain)

Following primary infection, T. gondii tachyzoites disseminate throughout the body via the bloodstream and lymphatics [2]. The parasite has a marked tropism for neural and muscular tissues, with the brain being a primary site for cyst formation [17, 2]. In the brain, tachyzoites convert to bradyzoites, forming quiescent tissue cysts that persist for the life of the host [8, 2]. Reactivation of these cysts can occur during immunosuppression, leading to recrudescent encephalitis [2].

Histopathological examination of brains from cats with clinical toxoplasmosis has demonstrated T. gondii in 80% of cases [17]. Lesions include multifocal necrosis, gliosis, perivascular cuffing, and meningitis [17, 18]. In a large case series of 100 cats with histologically confirmed toxoplasmosis, 7 presented with predominantly neurologic signs, including seizures, ataxia, and behavioral changes [17]. Ocular involvement, including iridocyclochoroiditis, was found in 81.5% of cats examined, and the ciliary body was the most severely affected portion of the uvea [17]. Neonatal toxoplasmosis presents with severe encephalitis, hydrocephalus, and cerebellar hypoplasia [17, 19].

Experimental studies using cyst-induced toxoplasmosis have shown that the severity of brain infection is dose-dependent, with higher inocula leading to more severe neurologic signs [9, 20]. The immune response, particularly cell-mediated immunity involving CD8+ T cells and production of IFN-gamma, is critical for controlling tachyzoite replication and maintaining latency [21]. Immunosuppressive conditions, such as concurrent infection with feline immunodeficiency virus, can lead to reactivation and severe encephalitis [22].

Clinical Manifestations in Cats

Clinical toxoplasmosis in cats is relatively rare despite high seroprevalence rates [17, 2, 16]. Most infected cats are asymptomatic [23]. When disease occurs, it can manifest as generalized, pulmonary, abdominal, or neurological forms [17, 2]. A case series of 100 cats identified generalized toxoplasmosis in 36 cats, pulmonary lesions in 26, abdominal lesions in 16, and neurologic lesions in 7 [17]. Common clinical signs include fever (73% of cats), dyspnea, polypnea, abdominal discomfort, anorexia, and lethargy [17, 24]. Ocular signs, including uveitis, chorioretinitis, and anterior chamber inflammation, are frequently observed [25, 17, 26, 2].

Neurological signs are a hallmark of cat toxoplasmosis brain and can include ataxia, circling, head pressing, seizures, and personality changes [25, 17, 2]. A retrospective pathology review of 126 zoo animal cases found that non-specific signs (anorexia, weight loss, lethargy), along with neurological, gastrointestinal, and respiratory signs, dominated clinically [18]. Pallas' cats (Otocolobus manul) are exceptionally susceptible to juvenile toxoplasmosis, with mortality rates up to 71.59% in the first year of life due to systemic and encephalitic toxoplasmosis [27].

Diagnostic Approaches

Diagnosis of toxoplasmosis in cats relies on a combination of serological, molecular, and cytological methods [3, 1, 2].

Serological Testing. Serology is the most common method for detecting exposure to T. gondii [3, 1, 23]. The modified agglutination test (MAT) using formalin-preserved tachyzoites is considered highly sensitive and specific for detecting antibodies in cats, often yielding higher titers than tests using acetone-preserved antigens [23]. Enzyme-linked immunosorbent assays (ELISA) for IgG and IgM are widely used in commercial laboratories and research settings [5, 14, 11]. The detection of IgM antibodies suggests recent exposure or reactivation, while IgG indicates chronic infection [14]. An indirect immunofluorescence antibody test (IFAT) is another validated method [5, 13, 15]. Recent work comparing recombinant antigens has shown that GRA7 is more sensitive than SAG2 or GRA6 for serodiagnosis in cats [11]. A study in Turkey evaluated immunochromatographic rapid test kits and found them to be a viable, cost-effective option for clinical screening, reporting a 6% prevalence in a hospital population [3].

Molecular Detection. Polymerase chain reaction (PCR) targeting T. gondii DNA from blood, aqueous humor, cerebrospinal fluid, or feces provides definitive evidence of active infection [14, 7, 11]. Real-time PCR methods have been used to detect T. gondii DNA in fecal samples from stray cats, with one study reporting a prevalence of 14.37% by real-time PCR [7]. PCR is essential for genotyping, which can identify strains associated with severe disease [1, 16].

Cytological and Histopathological Examination. Cytology of tracheal aspirates, pleural fluid, or biopsy specimens can reveal tachyzoites in acute cases [17]. Histopathology with immunohistochemical staining using anti-T. gondii serum is the gold standard for postmortem diagnosis [17, 18]. In the large zoo pathology review, histopathology and immunohistochemistry were used to confirm toxoplasmosis in 126 submissions from 32 zoos [18].

The diagnostic decision-making process is summarized in the following figure:

flowchart TD
    A[Suspected Feline Toxoplasmosis], > B{Clinical Signs}
    B, > C[Neurologic / Ocular Signs]
    B, > D[Systemic / Respiratory / Abdominal Signs]
    C, > E{Serology}
    D, > E
    E, > F[IgG+/IgM- or IgG-]
    E, > G[IgM+ or IgG+/IgM+]
    F, > H[Chronic / Latent Infection]
    G, > I[Active / Recent Infection / Reactivation]
    I, > J[Molecular Testing]
    J, > K[PCR on Blood, CSF, Aqueous Humor, or Feces]
    K, > L[Positive]
    K, > M[Negative]
    L, > N[Confirm Active Toxoplasmosis]
    M, > O[Consider Other Etiologies]
    H, > P[No Treatment Required; Monitor]
    N, > Q[Initiate Antiprotozoal Therapy]

Treatment and Management

Treatment of clinical toxoplasmosis in cats is indicated for animals with active disease, especially those with neurologic, ocular, or systemic signs [28, 2, 10]. The most commonly used therapeutic agent is clindamycin (administered at 10 to 20 mg/kg orally every 12 hours for 4 weeks) [28, 2, 27]. A paradoxical effect of clindamycin has been observed in experimental acute toxoplasmosis, with some cats developing more severe disease if treatment is started during the enteroepithelial stage [28]. Nonetheless, clindamycin is considered the first-line treatment for clinical toxoplasmosis [2]. A prophylactic clindamycin protocol (25 mg/kg twice daily for 3 weeks around predicted exposure periods) successfully reduced first-year mortality in Pallas' cat kittens from 100% to 5.88% in treated collections [27].

Alternative treatments include trimethoprim-sulfonamide combinations and ponazuril, though clinical experience is more limited [2]. Adjunctive therapy with corticosteroids may be necessary for cats with severe ocular or neurologic inflammation [2].

Control and Prevention

Control of zoonotic transmission from cats requires a multi-faceted approach targeting both oocyst shedding and human exposure [1, 10, 7]. The primary preventive measures include:

• Feces Management. Daily removal of cat feces from litter boxes prevents sporulation, as oocysts require 1-5 days to become infectious [1, 10]. Litter boxes should be cleaned daily with hot water and disinfected with ammonium-based or chlorhexidine compounds [10]. Pregnant women and immunocompromised individuals should avoid handling cat litter [4].

• Indoor Housing. Keeping cats indoors reduces their exposure to infected prey and thus reduces the risk of acquiring and shedding T. gondii [13, 14, 12]. Semi-domesticated and stray cats represent the highest zoonotic risk [13, 7].

• Dietary Management. Cats should not be fed raw or undercooked meat, as this is a major source of tissue cyst acquisition [1, 2, 16]. Commercial cooked or canned diets are safe.

• Environmental Sanitation. Covering children's sandboxes and preventing cat access to vegetable gardens reduces oocyst contamination of soil and water [5, 12].

• Stray Cat Population Control. Reducing the number of free-roaming cats through trap-neuter-return programs can decrease environmental contamination with oocysts [7, 18].

• Vaccination. A live attenuated RHΔompdcΔuprt mutant vaccine has shown promise in experimental studies, reducing oocyst shedding numbers by 95.3% in immunized cats compared with non-immunized controls [21]. This vaccine is not yet commercially available but represents a significant advancement in reducing environmental contamination at the source.

Conclusions

Toxoplasmosis in cats is a critical zoonotic disease of global importance, with the feline definitive host serving as the sole source of environmental oocyst contamination [1, 5]. The ability of cats to excrete millions of oocysts creates a persistent infection pressure for all warm-blooded animals, including humans [1, 6]. Feline brain infection (cat toxoplasmosis brain) is a significant clinical entity, with neurotropism leading to cyst formation in the cerebrum and cerebellum, and reactivation causing encephalitis and neurologic signs [17, 2]. Diagnosis requires a combination of serological, molecular, and histopathological methods [3, 1, 11]. Treatment with clindamycin is effective for active disease, and prevention hinges on reducing oocyst shedding through indoor housing, dietary management, and strict hygiene protocols [28, 2]. Oocyst shedding from cat feces (toxoplasmosis in cat poop) remains the primary route of environmental contamination, and control strategies must prioritize stray cat management and public education to mitigate the zoonotic risk.

References

[1] Dubey, J., Cerqueira-Cezar, C. K., Murata, F., et al. (2020). All about toxoplasmosis in cats: the last decade. Veterinary Parasitology.

[2] Calero-Bernal, R., & Gennari, S. (2019). Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science.

[3] Parlatir, Y., Senel, Y., & Kara, E. (2025). Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kirikkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science.

[4] Hasan, M. F., Harun, A., Hossain, D., et al. (2024). Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases.

[5] Fux, B., Covre, K., Lopes, R., et al. (2020). Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition.

[6] Selyemova, D., Antolova, D., Mangova, B., et al. (2024). Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Current Research in Parasitology and Vector-Borne Diseases.

[7] Karakavuk, M., Can, H., Selim, N., et al. (2021). Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in Izmir, Turkey. Journal of Infection in Developing Countries.

[8] Dubey, J. (1986). Toxoplasmosis in cats. Journal.

[9] Dubey, J., & Frenkel, J. K. (1972). Cyst-induced toxoplasmosis in cats. The Journal of Protozoology.

[10] Frenkel, J. K. (1978). Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases.

[11] Sabukunze, S., Gu, H., Zhao, L., et al. (2024). Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science.

[12] Zakaria, R., & Ardiansyah, S. (2020). Potential Analysis Of Toxoplasmosis Distribution In Wild Cats (Felis silvestris) In Some Markets Of Sidoarjo District Through Microscopic Identification Of Toxoplasma gondii. Medicra (Journal of Medical Laboratory Science/Technology).

[13] Inpankaew, T., Sattasathuchana, P., Kengradomkij, C., et al. (2021). Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research.

[14] Majid, A., Ahmad, N., Haleem, S., et al. (2021). Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research.

[15] Kokkinaki, K. G., Saridomichelakis, M., Mylonakis, M., et al. (2023). Seroprevalence of and Risk Factors for Toxoplasma gondii Infection in Cats from Greece. Animals.

[16] Crouch, E. E. V., Mittel, L., Southard, T., et al. (2019). Littermate cats rescued from a shelter succumbed to acute, primary toxoplasmosis associated with TOXO DB genotype #4, generally circulating in wildlife. Parasitology International.

[17] Dubey, J., & Carpenter, J. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association.

[18] Denk, D., De Neck, S., Khaliq, S., et al. (2022). Toxoplasmosis in Zoo Animals: A Retrospective Pathology Review of 126 Cases. Animals. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[19] Dubey, J., Mattix, M., & Lipscomb, T. (1996). Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement.

[20] Dubey, J. P., Hoover, E., & Walls, K. (1977). Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology.

[21] Shen, Y., Zheng, B., Sun, H., et al. (2023). A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty.

[22] Munhoz, A., Hage, S. B., Cruz, R., et al. (2017). Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports.

[23] Dubey, J., & Thulliez, P. (1989). Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association.

[24] Bastan, I. (2018). Clinical and some laboratory findings in cats with Toxoplasmosis. Journal.

[25] Cucos, C., Ionascu, I., Mocanu, J., et al. (2015). Neurological and ocular form of toxoplasmosis in cats. Journal.

[26] Vainisi, S. J., & Campbell, L. H. (1969). Ocular toxoplasmosis in cats. Journal.

[27] Girling, S., Pizzi, R., Naylor, A., et al. (2020). Use of clindamycin in Pallas' cats (Otocolobus manul) to reduce juvenile toxoplasmosis-associated mortality rates. Journal of Zoo and Wildlife Medicine.

[28] Davidson, M. G., Lappin, M., Rottman, J. R., et al. (1996). Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy.

[29] Ahmad, N., Ahmed, H., Irum, S., et al. (2014). Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine.

[30] Al-Kappany, Y., Rajendran, C., Ferreira, L. R., et al. (2010). High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology.

[31] Shahzad, A., Khan, M. S., Ashraf, K., et al. (2006). Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal.

[32] Zafar, Z., Ali, N., & Baleanu, D. (2021). Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal.

[33] Germano, P. M., Melo, H., Bianchin, I., et al. (1980). Toxoplasmosis in cats and dogs. Journal.

[34] Vinogradov, L. I. (1980). Diagnosis of toxoplasmosis in cats. Journal.

[35] Dubey, J. P., Lehmann, T., Lautner, F., et al. (2015). Toxoplasmosis in sentinel chickens (Gallus domesticus) in New England farms: Seroconversion, distribution of tissue cysts in brain, heart, and skeletal muscle by bioassay in mice and cats. Veterinary Parasitology.